Literature DB >> 24347523

Extremely obese children respond better than extremely obese adolescents to lifestyle interventions.

C Knop1, V Singer, Y Uysal, A Schaefer, B Wolters, T Reinehr.   

Abstract

UNLABELLED: What is already known about this subject Lifestyle intervention is regarded as therapy of choice in obese children and adolescents. It is unclear whether extremely obese children and adolescents respond to lifestyle intervention. What this study adds Extremely obese children respond better than obese children to a lifestyle intervention. In contrast, most extremely obese adolescents achieved no weight loss in lifestyle intervention suggesting that other treatment approaches are needed for them.
BACKGROUND: There are conflicting results of treating extreme obesity in childhood by lifestyle interventions in the literature.
METHODS: We analysed the outcome of a 1-year lifestyle intervention in an intention-to-treat approach in 1291 children (mean age 11.0 ± 2.5 years, mean body mass index [BMI] 27.5 ± 4.7 kg m(-2), 55.8% female, 62.4% obese, 37.6% extremely obese (defined by BMI-SDS >2.3) at end of intervention and 1 year later.
RESULTS: The mean BMI-SDS reduction was -0.20 ± 0.32 at end of intervention and -0.14 ± 0.37 1 year after end of intervention compared to baseline (comparing intervention vs. 1 year later P = 0.010). Extremely obese children ≤10 years demonstrated a significantly greater BMI-SDS reduction than obese children ≤10 years (-0.24 ± 0.38 vs. -0.16 ± 0.38, P = 0.021). Extremely obese adolescents >10 years demonstrated a significantly lower BMI-SDS reduction compared to obese adolescents >10 years (-0.05 ± 0.30 vs. -0.15 ± 0.39, P < 0.001). Comparing the BMI-SDS reduction between obese children <10 years and >10 years revealed no significant difference (P = 0.195) in contrast to the comparison between extremely obese children <10 years and >10 years (P < 0.001). The same findings were observed in the follow-up period after the end of intervention.
CONCLUSIONS: Our study demonstrated an encouraging effect of lifestyle intervention in extremely obese children ≤10 years at the end of intervention and 1 year later, but only a limited effect in extremely obese adolescents >10 years.
© 2013 The Authors. Pediatric Obesity © 2013 International Association for the Study of Obesity.

Entities:  

Keywords:  Adolescents; age; children; extreme obesity; weight loss

Mesh:

Year:  2013        PMID: 24347523     DOI: 10.1111/j.2047-6310.2013.00212.x

Source DB:  PubMed          Journal:  Pediatr Obes        ISSN: 2047-6302            Impact factor:   4.000


  32 in total

1.  Weight change in the management of youth-onset type 2 diabetes: the TODAY clinical trial experience.

Authors:  M D Marcus; D E Wilfley; L El Ghormli; P Zeitler; B Linder; K Hirst; C E Ievers-Landis; D J van Buren; N Walders-Abramson
Journal:  Pediatr Obes       Date:  2016-05-10       Impact factor: 4.000

2.  Topiramate for weight reduction in adolescents with severe obesity.

Authors:  Claudia K Fox; Kara L Marlatt; Kyle D Rudser; Aaron S Kelly
Journal:  Clin Pediatr (Phila)       Date:  2014-07-14       Impact factor: 1.168

3.  A Structured, Manual-Based Low-Level Intervention vs. Treatment as Usual Evaluated in a Randomized Controlled Trial for Adolescents with Extreme Obesity - the STEREO Trial.

Authors:  Yvonne Mühlig; André Scherag; Annika Bickenbach; Ulrike Giesen; Reinhard Holl; Rolf Holle; Wieland Kiess; Belinda Lennerz; Diana Lütke Brintrup; Anja Moss; Madlen Neef; Claudia Ose; Thomas Reinehr; Christina M Teuner; Susanna Wiegand; Barbara Wolters; Martin Wabitsch; Johannes Hebebrand
Journal:  Obes Facts       Date:  2017-08-09       Impact factor: 3.942

4.  Pediatric severe obesity: time to establish serious treatments for a serious disease.

Authors:  Stephen R Daniels; Aaron S Kelly
Journal:  Child Obes       Date:  2014-07-01       Impact factor: 2.992

5.  Predictors of weight-loss response with glucagon-like peptide-1 receptor agonist treatment among adolescents with severe obesity.

Authors:  B M Nathan; K D Rudser; M J Abuzzahab; C K Fox; B J Coombes; E M Bomberg; A S Kelly
Journal:  Clin Obes       Date:  2015-12-18

Review 6.  Working toward precision medicine approaches to treat severe obesity in adolescents: report of an NIH workshop.

Authors:  Aaron S Kelly; Marsha D Marcus; Jack A Yanovski; Susan Z Yanovski; Stavroula K Osganian
Journal:  Int J Obes (Lond)       Date:  2018-10-03       Impact factor: 5.095

7.  Changes in Functional Mobility and Musculoskeletal Pain After Bariatric Surgery in Teens With Severe Obesity: Teen-Longitudinal Assessment of Bariatric Surgery (LABS) Study.

Authors:  Justin R Ryder; Nicholas M Edwards; Resmi Gupta; Jane Khoury; Todd M Jenkins; Sharon Bout-Tabaku; Marc P Michalsky; Carroll M Harmon; Thomas H Inge; Aaron S Kelly
Journal:  JAMA Pediatr       Date:  2016-09-01       Impact factor: 16.193

8.  Design of a randomized controlled trial to decrease depression and improve insulin sensitivity in adolescents: Mood and INsulin sensitivity to prevent Diabetes (MIND).

Authors:  Lauren B Shomaker; Lauren Gulley; Allison M Hilkin; Emma Clark; Shelly Annameier; Sangeeta Rao; Bonny Rockette-Wagner; Andrea Kriska; Kenneth P Wright; Eric Stice; Kristen J Nadeau; Megan M Kelsey
Journal:  Contemp Clin Trials       Date:  2018-10-17       Impact factor: 2.226

Review 9.  Pediatric obesity pharmacotherapy: current state of the field, review of the literature and clinical trial considerations.

Authors:  A S Kelly; C K Fox; K D Rudser; A C Gross; J R Ryder
Journal:  Int J Obes (Lond)       Date:  2016-04-26       Impact factor: 5.095

10.  Impact of an Electronic Template on Documentation of Obesity in a Primary Care Clinic.

Authors:  Vidhu V Thaker; Felix Lee; Clement J Bottino; Cassandra L Perry; Ingrid A Holm; Joel N Hirschhorn; Stavroula K Osganian
Journal:  Clin Pediatr (Phila)       Date:  2015-12-15       Impact factor: 1.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.